Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.
about
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathwayExamination of the Anti-Inflammatory, Antioxidant, and Xenobiotic-Inducing Potential of Broccoli Extract and Various Essential Oils during a Mild DSS-Induced Colitis in Rats.Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host.Effect of Bacillus subtilis on Aeromonas hydrophila-induced intestinal mucosal barrier function damage and inflammation in grass carp (Ctenopharyngodon idella).Dietary soy isoflavones alleviate dextran sulfate sodium-induced inflammation and oxidative stress in mice.CXCR4 antagonist AMD3100 modulates claudin expression and intestinal barrier function in experimental colitisClaudin-2 as a mediator of leaky gut barrier during intestinal inflammation.Evidence for a causal link between adaptor protein PDZK1 downregulation and Na⁺/H⁺ exchanger NHE3 dysfunction in human and murine colitisEmodin promoted pancreatic claudin-5 and occludin expression in experimental acute pancreatitis rats.Changes in the phosphorylation of claudins during the course of experimental colitisCorticosterone mediates stress-related increased intestinal permeability in a region-specific manner.Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegenerationHerb-partitioned moxibustion upregulated the expression of colonic epithelial tight junction-related proteins in Crohn's disease model ratsIrinotecan disrupts tight junction proteins within the gut : implications for chemotherapy-induced gut toxicity.MKP-1 attenuates LPS-induced blood-testis barrier dysfunction and inflammatory response through p38 and IκBα pathways.Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.Claudins and other tight junction proteins.Modeling bioavailability to organs protected by biological barriers.Claudin clusters as determinants of epithelial barrier function.Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity.Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive systemDisruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.The epithelial barrier and beyond: Claudins as amplifiers of physiological organ functions.Effects of quercetin studied in colonic HT-29/B6 cells and rat intestine in vitro.Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.Perspectives on tight junction research.Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8.Tight Junction Ultrastructure Alterations in a Mouse Model of Enteral Nutrient Deprivation.AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway.Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.Porcine milk induces a strengthening of barrier function in porcine jejunal epithelium in vitro.Pyrrolidine Dithiocarbamate Inhibits NF-KappaB Activation and Upregulates the Expression of Gpx1, Gpx4, Occludin, and ZO-1 in DSS-Induced Colitis.Activation of muscarinic cholinoceptor ameliorates tumor necrosis factor-α-induced barrier dysfunction in intestinal epithelial cells.Sphingomyelin and phosphatidylcholine contrarily affect the induction of apoptosis in intestinal epithelial cells.Severe Burn-Induced Intestinal Epithelial Barrier Dysfunction Is Associated With Endoplasmic Reticulum Stress and Autophagy in Mice.
P2860
Q26777641-2856DE4C-351B-4902-BE6C-28964104199CQ28487645-045F983A-1C4F-48D3-80C4-8A44A9245870Q30317855-1030F9B6-C56F-4DE3-8359-657E2656A51DQ30412140-652B7744-B2A0-4DFA-8651-FE3E9B53F73AQ33685620-A9347693-2CCE-46CF-8C3F-E73238EEC761Q33846821-1EC4CAC2-0728-46ED-92E0-AADD466B1A25Q34071898-C93E14A8-F90F-4283-9A8C-A24A0265E8F9Q35212830-1CB62CC4-72C7-4F94-9FF4-88B2B7205791Q35252041-D7CEDD36-59DF-4301-8294-3472753F5ACEQ35929216-4B1D6179-F6C6-4322-850F-62B0B4C69009Q36375073-7BB3BFE0-7CAE-480C-8C2F-8B9E82D6E293Q36573670-8C2A8D6B-6F57-48E0-AE75-8E72E9D969FBQ36711812-754A82F1-0434-4342-9630-19B4DB64CC7BQ36836944-FF80835F-9672-4D8E-9B11-2DF6430C9195Q37591476-968D109E-C53E-4C02-9903-77F99A5A9231Q37709043-B2FC1316-B26C-411E-806B-4DD0B17225DCQ37973313-53EE266C-0A4B-422A-A696-651283AC0653Q38110750-4763A144-5A4F-4239-9025-2E06ABF5DBEFQ38288015-4731ED1D-06FF-4B89-BCFF-14FADBAFD566Q38383384-D46BB2BF-85E0-4D40-8E00-014F59B3E426Q39007546-C1EF8615-ECD7-487B-B51F-7890117FB67FQ39029301-6F9B8255-02B1-46BF-9C7A-0128A19D709BQ39189861-97A032AB-9CA1-4028-9694-B9C18D7B1D07Q39216312-36D74531-3C6E-4A2D-9BB3-AB5B75037CBDQ39325617-336F43AE-6109-4D08-BC5E-12A3C28CAC3AQ39339639-5A9518D3-76BF-494C-AD92-D7629CDC6553Q39579734-64667874-1BFA-49AB-A199-2DE8CCA6F163Q39607231-4FF8163F-4880-437A-90D5-06B05879FFA9Q40352387-9FE01B70-1795-4913-ADC8-39C8125B6DE5Q40864710-3D9DB805-5BB0-4137-BD9A-44076BFF7351Q41889693-220479A6-BBDE-4BBD-9A00-02AFF17E2A2CQ42248209-4D044D03-4EBC-4742-A903-FA489D8431BBQ47803871-2D604839-207F-413D-9E20-49B09C0DD8F6Q50920142-459D8243-FB24-43FD-9843-8DF60915126DQ51033857-9DEDB8A5-B779-427E-A8CC-8FC86C1ECD30Q51333250-9600383D-DD7E-48FF-8947-1179F352B28DQ52665019-12766E8A-63BD-419B-AB82-2E4018E784AAQ53085881-2BB36944-0015-453D-B0A3-06412A9C9FD1Q55517489-3DFEAC15-1BD0-47B2-8170-2CBC354A5E52
P2860
Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Regulation of mucosal structur ...... atory bowel disease cytokines.
@ast
Regulation of mucosal structur ...... atory bowel disease cytokines.
@en
type
label
Regulation of mucosal structur ...... atory bowel disease cytokines.
@ast
Regulation of mucosal structur ...... atory bowel disease cytokines.
@en
prefLabel
Regulation of mucosal structur ...... atory bowel disease cytokines.
@ast
Regulation of mucosal structur ...... atory bowel disease cytokines.
@en
P2093
P2860
P1476
Regulation of mucosal structur ...... atory bowel disease cytokines.
@en
P2093
Anja Fromm
Ingo Grotjohann
Johan D Söderholm
Jörg-Dieter Schulzke
Maren Amasheh
Martin Zeitz
Salah Amasheh
P2860
P304
P356
10.1080/00365520903131973
P577
2009-01-01T00:00:00Z